NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-108-2006-0-CL-05 Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods CL ORD 2005-2865 Abandoned
NCI E-312-2005-0-US-01 Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer US 60/733,319 Abandoned
NCI E-030-2006-0-US-01 INHIBITORS OF PLK1 AND USES THEREOF US 60/733,357 Abandoned
NICHD E-023-2006-0-US-01 Method Evolved For Recognition And Testing of Age Related Macular Degeneration(MERT-ARMD) US 60/733,042 Abandoned
NICHD E-107-2003-0-RU-08 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi RU National Stage 2005133709 Abandoned
NCI E-049-2006-0-ZA-03 Combination Approaches For Generating Immune Responses ZA National Stage 2007/03394 Abandoned
NCI E-049-2006-0-PCT-02 Combination Approaches For Generating Immune Responses PCT PCT PCT/US2005/039558 Expired
NCI E-049-2006-0-CN-05 Combination Approaches For Generating Immune Responses CN National Stage 200580037821.1 Abandoned
NCI E-049-2006-0-EP-10 Combination Approaches For Generating Immune Responses EP DIV 10178110.2 Abandoned
NCI E-049-2006-0-EP-08 Combination Approaches For Generating Immune Responses EP National Stage 05816142.3 Abandoned
NCI E-049-2006-0-CA-06 Combination Approaches For Generating Immune Responses CA National Stage 2585672 Abandoned
NCI E-333-2005-0-US-01 Method of Screening For Hepatocellular Carcinoma US 60/732,332 Abandoned
NCI E-049-2006-0-IN-04 Combination Approaches For Generating Immune Responses IN National Stage 1551/KOLNP/2007 Abandoned
NHLBI E-183-2004-1-CA-03 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS CA National Stage 2589034 Issued
NHLBI E-183-2004-1-JP-05 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS JP National Stage 2007-539250 Issued
NHLBI E-183-2004-1-HK-07 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS HK EP 07112550.0 Abandoned
NHLBI E-183-2004-1-EP-04 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS EP National Stage 05821237.4 Issued
NHLBI E-183-2004-1-GB-12 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS GB EP 05821237.4 Issued
NHLBI E-183-2004-1-FR-11 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS FR EP 05821237.4 Issued
NHLBI E-183-2004-1-DE-10 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS DE EP 05821237.4 Issued
NHLBI E-183-2004-1-AU-02 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS AU National Stage 2005302291 Issued
NHLBI E-183-2004-1-PCT-01 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS PCT PCT COMB PCT/US2005/039282 Expired
NHLBI E-190-2003-1-US-01 Protein Arginine N-methyltransferase 2 (PRMT2) US CIP 11/263,657 Abandoned
NCI E-003-2006-0-US-01 Antibodies and Immunotoxins that Target Human Glycoprotein NMB US 60/732,227 Abandoned
NCI E-279-2005-0-US-01 Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates US 60/731,946 Abandoned
NCI E-251-2004-0-PCT-02 Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies PCT PCT PCT/US2005/39175 Expired
NIA E-108-2006-0-PCT-02 Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods PCT PCT PCT/US2005/39184 Expired
NIA E-108-2006-0-US-03 Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods US ORD 11/261,121 Abandoned
NCI E-251-2004-0-EP-05 Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies EP National Stage 05819487.9 Abandoned
NIAID E-324-2005-2-US-01 Conformationally Stablilized HIV Envelope Immunogens and Triggering HIV-1 Envelope to Reveal Cryptic V3-Loop Epitopes US 60/731,627 Abandoned
NIEHS E-184-2005-0-US-01 Targeting ABCA13 Transporter to Control Hyperlipidema. US 60/731,380 Abandoned
NCI E-251-2004-0-AU-06 Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies AU National Stage 2005302416 Abandoned
NCI E-251-2004-0-CA-04 Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies CA National Stage 2585574 Abandoned
NIDCD E-217-2001-0-US-06 Intranasal Immunization With Detoxified Lipooligosaccharide From Nontypeable Haemophilus Influenzae or Moraxella Catarrhalis US CON 11/260,773 7641906 Expired PDF
NHLBI E-338-2007-3-US-01 Methods And Apparatus For Creating Particle Derivatives Of HDL With Reduced Lipid Content US CIP 11/260,861 7393826 Expired PDF
NIA E-172-2004-0-PCT-02 Novel Anticholinesterases Based On The Molecular Skeletons Of Furobenzofuran And Benzodioexepine PCT PCT PCT/US2005/038400 Abandoned
NIAID E-324-2005-1-US-01 Conformationally Stabilized HIV Envelope Immunogens and Triggering HIV-1 Envelope to Reveal Cryptic
V-3 Loop Epitopes 		US 60/729,878 Abandoned
NIDCR E-331-2002-0-US-03 Activation of Recombinant Diphtheria Toxin Fusion Proteins By Specific Proteases Highly Expressed on the Surface of Tumor Cells US National Stage 10/554,076 Abandoned
NCI E-018-2002-0-US-03 Application of Spliceosome-Mediated RNA Trans-Splicing (SMART tm) Gene Therapy To The Treatment of Human Papillimavirus... US National Stage 11/256,585 Expired
NCI E-221-1993-3-HK-26 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders HK National Stage 05109253.8 Abandoned
NHGRI E-315-2001-0-US-07 Alteration of RAB38 function to modulate mammalian pigmentation US National Stage 10/501,611 Abandoned
NCI E-244-2005-0-US-01 In Situ Assembling Of Protein Microarrays US ORD 11/252,735 8148302 Issued PDF
NIDCR E-258-1998-0-US-04 Hybrid Adeno-Retroviral Vector For the Transfection of Cells US CON 11/255,059 7618623 Abandoned PDF
NCI E-263-2004-0-PCT-02 POT1 Alternative Splicing Variants PCT PCT PCT/US2005/037957 Expired
NCI E-311-2004-0-PCT-02 Glucopyranoside Molecules With Surface Active Properties Completely Protect Cells From Ultrasound Induced Cytolysis Over A Broad Range Of Ultrasound Frequency And Intensity Conditions PCT PCT PCT/US2005/037912 Abandoned
NCI E-311-2004-0-US-03 METHODS AND COMPOSITIONS FOR PROTECTING CELLS FROM ULTRASOUND-MEDIATED CYTOLYSIS US ORD 11/577,555 Abandoned
NCI E-311-2004-0-EP-05 Glucopyranoside Molecules With Surface Active Properties Completely Protect Cells From Ultrasound Induced Cytolysis Over A Broad Range Of Ultrasound Frequency And Intensity Conditions EP National Stage 05816000.3 Abandoned
NIAMS E-010-2005-1-US-01 Generation Of Regulatory T-cells For Immunotherapy US 60/728,475 Abandoned
NCI E-311-2004-0-CA-04 METHODS AND COMPOSITIONS FOR PROTECTING CELLS FROM ULTRASOUND-MEDIATED CYTOLYSIS CA National Stage 2584299 Abandoned
NCI E-311-2004-0-AU-07 METHODS AND COMPOSITIONS FOR PROTECTING CELLS FROM ULTRASOUND-MEDIATED CYTOLYSIS AU National Stage 2005295261 Abandoned